Published in Genet Med on August 12, 2002
Rare variants create synthetic genome-wide associations. PLoS Biol (2010) 14.43
Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat Res (2008) 3.76
GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet (2005) 2.63
Interpretation of association signals and identification of causal variants from genome-wide association studies. Am J Hum Genet (2010) 2.06
A novel hearing-loss-related mutation occurring in the GJB2 basal promoter. J Med Genet (2007) 1.62
A genotype-phenotype correlation for GJB2 (connexin 26) deafness. J Med Genet (2004) 1.56
Gap junctions and cochlear homeostasis. J Membr Biol (2006) 1.41
DNA sequence analysis of GJB2, encoding connexin 26: observations from a population of hearing impaired cases and variable carrier rates, complex genotypes, and ethnic stratification of alleles among controls. Am J Med Genet A (2006) 1.28
Molecular epidemiology of DFNB1 deafness in France. BMC Med Genet (2004) 1.24
Altered gating properties of functional Cx26 mutants associated with recessive non-syndromic hearing loss. Hum Genet (2004) 1.17
Genotyping with a 198 mutation arrayed primer extension array for hereditary hearing loss: assessment of its diagnostic value for medical practice. PLoS One (2010) 1.17
Pathogenetic role of the deafness-related M34T mutation of Cx26. Hum Mol Genet (2006) 1.14
Whole-exome sequencing identifies MYO15A mutations as a cause of autosomal recessive nonsyndromic hearing loss in Korean families. BMC Med Genet (2013) 1.07
Hereditary non-syndromic sensorineural hearing loss: transforming silence to sound. J Mol Diagn (2004) 1.02
A population-based study of autosomal-recessive disease-causing mutations in a founder population. Am J Hum Genet (2012) 1.00
Hearing loss: a common disorder caused by many rare alleles. Ann N Y Acad Sci (2010) 1.00
Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss. Genetic Evaluation of Congenital Hearing Loss Expert Panel. ACMG statement. Genet Med (2002) 0.98
Prevalence of p.V37I variant of GJB2 in mild or moderate hearing loss in a pediatric population and the interpretation of its pathogenicity. PLoS One (2013) 0.96
Detection of mutations in genes associated with hearing loss using a microarray-based approach. J Mol Diagn (2006) 0.96
Genetic mutations in non-syndromic deafness patients of Uyghur and Han Chinese ethnicities in Xinjiang, China: a comparative study. J Transl Med (2011) 0.95
Prioritizing genetic variants for causality on the basis of preferential linkage disequilibrium. Am J Hum Genet (2012) 0.94
A novel DFNB1 deletion allele supports the existence of a distant cis-regulatory region that controls GJB2 and GJB6 expression. Clin Genet (2010) 0.93
Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. Hum Genet (2016) 0.93
Connexin26 (GJB2) deficiency reduces active cochlear amplification leading to late-onset hearing loss. Neuroscience (2014) 0.92
Phenotypic variability of patients homozygous for the GJB2 mutation 35delG cannot be explained by the influence of one major modifier gene. Eur J Hum Genet (2008) 0.91
Massively Parallel Sequencing for Genetic Diagnosis of Hearing Loss: The New Standard of Care. Otolaryngol Head Neck Surg (2015) 0.91
A deafness-associated mutant human connexin 26 improves the epithelial barrier in vitro. J Membr Biol (2007) 0.90
3p-- syndrome defines a hearing loss locus in 3p25.3. Hear Res (2007) 0.88
Examining the relationship between genetic counselors' attitudes toward deaf people and the genetic counseling session. J Genet Couns (2009) 0.88
Two tyrosine-based sorting signals in the Cx43 C-terminus cooperate to mediate gap junction endocytosis. Mol Biol Cell (2013) 0.87
Identification of CDH23 mutations in Korean families with hearing loss by whole-exome sequencing. BMC Med Genet (2014) 0.85
First molecular screening of deafness in the Altai Republic population. BMC Med Genet (2005) 0.85
Mutation analysis of the SLC26A4, FOXI1 and KCNJ10 genes in individuals with congenital hearing loss. PeerJ (2014) 0.83
Characterising the spectrum of autosomal recessive hereditary hearing loss in Iran. J Med Genet (2015) 0.83
Allele-specific impairment of GJB2 expression by GJB6 deletion del(GJB6-D13S1854). PLoS One (2011) 0.82
Developing regional genetic counseling for southern Chinese with nonsyndromic hearing impairment: a unique mutational spectrum. J Transl Med (2014) 0.82
Audiological and electrocochleography findings in hearing-impaired children with connexin 26 mutations and otoacoustic emissions. Eur Arch Otorhinolaryngol (2007) 0.82
Correlation between GJB2 mutations and audiological deficits: personal experience. Eur Arch Otorhinolaryngol (2008) 0.81
A comprehensive introduction to the genetic basis of non-syndromic hearing loss in the Saudi Arabian population. BMC Med Genet (2011) 0.80
Connexins and gap junctions in the inner ear--it's not just about K⁺ recycling. Cell Tissue Res (2014) 0.80
Mutations of GJB2 encoding connexin 26 contribute to non-syndromic moderate and severe hearing loss in Pakistan. Eur Arch Otorhinolaryngol (2015) 0.79
Modifiers of hearing impairment in humans and mice. Curr Genomics (2010) 0.79
Identification of SLC26A4 c.919-2A>G compound heterozygosity in hearing-impaired patients to improve genetic counseling. J Transl Med (2012) 0.78
Genetics of non syndromic hearing loss in the republic of macedonia. Balkan J Med Genet (2012) 0.78
Potential treatments for genetic hearing loss in humans: current conundrums. Gene Ther (2015) 0.78
Factors influencing parental decision about genetics evaluation for their deaf or hard-of-hearing child. Genet Med (2009) 0.78
Temporal bone abnormalities in children with GJB2 mutations. Laryngoscope (2011) 0.78
Unraveling of Enigmatic Hearing-Impaired GJB2 Single Heterozygotes by Massive Parallel Sequencing: DFNB1 or Not? Medicine (Baltimore) (2016) 0.78
A genotype-phenotype correlation in Sicilian patients with GJB2 biallelic mutations. Eur Arch Otorhinolaryngol (2014) 0.77
C.35delG/ GJB2 and del(GJB6-D13S1830) mutations in Croatians with prelingual non-syndromic hearing impairment. BMC Ear Nose Throat Disord (2005) 0.77
The Study of SLC26A4 Gene Causing Autosomal Recessive Hearing Loss by Linkage Analysis in a Cohort of Iranian Populations. Int J Mol Cell Med (2014) 0.77
Application of SNPscan in Genetic Screening for Common Hearing Loss Genes. PLoS One (2016) 0.75
Screening of deafness-causing DNA variants that are common in patients of European ancestry using a microarray-based approach. PLoS One (2017) 0.75
GJB2 Mutation Spectrum and Genotype-Phenotype Correlation in 1067 Han Chinese Subjects with Non-Syndromic Hearing Loss. PLoS One (2015) 0.75
Genetic counseling for patients with nonsyndromic hearing impairment directed by gene analysis. Mol Med Rep (2016) 0.75
A recessive Mendelian model to predict carrier probabilities of DFNB1 for nonsyndromic deafness. Hum Mutat (2006) 0.75
Identification and genotype/phenotype correlation of mutations in a large German cohort with hearing loss. Eur Arch Otorhinolaryngol (2014) 0.75
ACEMg Diet Supplement Modifies Progression of Hereditary Deafness. Sci Rep (2016) 0.75
Single nucleotide polymorphisms of the GJB2 and GJB6 genes are associated with autosomal recessive nonsyndromic hearing loss. Biomed Res Int (2015) 0.75
A novel compound heterozygous mutation in the GJB2 gene causing non-syndromic hearing loss in a family. Int J Mol Med (2013) 0.75
Genetics: A New Frontier in Otology. Indian J Otolaryngol Head Neck Surg (2016) 0.75
Molecular investigation of pediatric portuguese patients with sensorineural hearing loss. Genet Res Int (2011) 0.75
Screening of DFNB3 in Iranian families with autosomal recessive non-syndromic hearing loss reveals a novel pathogenic mutation in the MyTh4 domain of the MYO15A gene in a linked family. Iran J Basic Med Sci (2016) 0.75
Rare compound heterozygosity involving dominant and recessive mutations of GJB2 gene in an assortative mating hearing impaired Indian family. Eur Arch Otorhinolaryngol (2016) 0.75
Prevalence of autism in a US metropolitan area. JAMA (2003) 10.37
Risk of bacterial meningitis in children with cochlear implants. N Engl J Med (2003) 3.75
Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics (2008) 2.88
Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Surveill Summ (2016) 2.60
A public health collaboration for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol (2007) 2.36
Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet (2002) 2.07
Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning - Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol (2013) 2.04
Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics (2002) 1.90
Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children. Genet Med (2010) 1.69
The relationship between autism and parenting stress. Pediatrics (2007) 1.65
Prevalence of four developmental disabilities among children aged 8 years--Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000. MMWR Surveill Summ (2006) 1.39
Prevalence and functioning of children with cerebral palsy in four areas of the United States in 2006: a report from the Autism and Developmental Disabilities Monitoring Network. Res Dev Disabil (2011) 1.39
Postservice mortality in Vietnam veterans: 30-year follow-up. Arch Intern Med (2004) 1.34
Prevalence of cerebral palsy: Autism and Developmental Disabilities Monitoring Network, three sites, United States, 2004. Disabil Health J (2009) 1.32
Concurrent medical conditions and health care use and needs among children with learning and behavioral developmental disabilities, National Health Interview Survey, 2006-2010. Res Dev Disabil (2011) 1.30
Evaluation of a records-review surveillance system used to determine the prevalence of autism spectrum disorders. J Autism Dev Disord (2011) 1.28
Cerebral palsy: classification and epidemiology. Phys Med Rehabil Clin N Am (2009) 1.25
Changes in autism spectrum disorder prevalence in 4 areas of the United States. Disabil Health J (2010) 1.23
Results from the New Jersey statewide critical congenital heart defects screening program. Pediatrics (2013) 1.20
Long-term speech and language developmental issues among children with Duarte galactosemia. Genet Med (2009) 1.18
Bacterial meningitis among children with cochlear implants beyond 24 months after implantation. Pediatrics (2006) 1.08
Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan atlanta. Pediatrics (2004) 1.03
A national action plan for promoting preconception health and health care in the United States (2012-2014). J Womens Health (Larchmt) (2013) 1.00
Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics (2009) 0.99
Children with cerebral palsy: racial disparities in functional limitations. Epidemiology (2012) 0.97
Committee Report: advancing the current recommended panel of conditions for newborn screening. Genet Med (2007) 0.94
Modeling the potential public health impact of prepregnancy obesity on adverse fetal and infant outcomes. Obesity (Silver Spring) (2013) 0.87
A population-based study of the recurrence of developmental disabilities--Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1991-94. Paediatr Perinat Epidemiol (2005) 0.86
Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children. Res Dev Disabil (2012) 0.84
Overview: the epidemiology of neurodevelopmental disorders. Ment Retard Dev Disabil Res Rev (2002) 0.84
Healthy behaviors and lifestyles in young adults with a history of developmental disabilities. Res Dev Disabil (2005) 0.83
Prevalence of developmental disabilities and receipt of special education services among children with an inborn error of metabolism. J Pediatr (2009) 0.83
Increased risk of death among children with Lennox-Gastaut syndrome and infantile spasms. J Child Neurol (2009) 0.83
Maternal infections during pregnancy and cerebral palsy: a population-based cohort study. Paediatr Perinat Epidemiol (2013) 0.82
Impact of postcensal versus intercensal population estimates on prevalence of selected developmental disabilities--metropolitan Atlanta, Georgia, 1991-1996. Am J Ment Retard (2007) 0.82
Congenital cerebral palsy and prenatal exposure to self-reported maternal infections, fever, or smoking. Am J Obstet Gynecol (2013) 0.81
Feasibility and reliability of classifying gross motor function among children with cerebral palsy using population-based record surveillance. Paediatr Perinat Epidemiol (2010) 0.80
Vital Signs: Update on Zika Virus-Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure - U.S. Zika Pregnancy Registry, 2016. MMWR Morb Mortal Wkly Rep (2017) 0.79
Effect of incorporating adaptive functioning scores on the prevalence of intellectual disability. Am J Intellect Dev Disabil (2011) 0.78
Predictors of ascertainment of autism spectrum disorders across nine US communities. J Autism Dev Disord (2013) 0.77
Future research directions to identify causes of the increasing incidence rate of congenital hypothyroidism in the United States. Pediatrics (2010) 0.77
Childhood vision impairment, hearing loss and co-occurring autism spectrum disorder. Disabil Health J (2013) 0.77
Dental care among young adults with intellectual disability. Res Dev Disabil (2013) 0.76
Genetic laboratory practices related to testing of the GJB2 (Connexin-26) gene in the United States in 1999 and 2000. Genet Test (2003) 0.76
An integrative perspective: mothers' influence on child health preconceptionally, prenatally, and in early childhood. Pediatrics (2003) 0.75